138 related articles for article (PubMed ID: 38141896)
1. Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies.
Xu Q; Elrefaei M; Taupin JL; Hitchman KMK; Hiho S; Gareau AJ; Iasella CJ; Marrari M; Belousova N; Bettinotti M; Narula T; Alvarez F; Sanchez PG; Levvey B; Westall G; Snell G; Levine DJ; Zeevi A; Roux A
J Heart Lung Transplant; 2024 Apr; 43(4):663-672. PubMed ID: 38141896
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
[TBL] [Abstract][Full Text] [Related]
3. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death.
Zazueta OE; Preston SE; Moniodis A; Fried S; Kim M; Townsend K; Wood I; Boukedes S; Guleria I; Camp P; El-Chemaly S; Rosas IO; Chandraker A; Milford E; Goldberg HJ
Transplantation; 2017 Sep; 101(9):2207-2212. PubMed ID: 27893614
[TBL] [Abstract][Full Text] [Related]
4. HLA-C mismatching improves outcomes following lung transplantation.
Hiho SJ; Levvey BJ; Diviney MB; Brooks AG; Holdsworth R; Snell GI; Westall GP; Sullivan LC
HLA; 2024 Jun; 103(6):e15544. PubMed ID: 38924641
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serial monitoring of donor-specific antibodies in pediatric and adult intestinal/multivisceral transplant recipients.
Klein K; Keck M; Langewisch E; Merani S; Hitchman K; Leick M
Pediatr Transplant; 2024 Feb; 28(1):e14638. PubMed ID: 37942670
[TBL] [Abstract][Full Text] [Related]
6. Donor-specific and -nonspecific HLA antibodies and outcome post lung transplantation.
Verleden SE; Vanaudenaerde BM; Emonds MP; Van Raemdonck DE; Neyrinck AP; Verleden GM; Vos R
Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29146602
[TBL] [Abstract][Full Text] [Related]
7. De Novo DQ Donor-Specific Antibodies Are Associated with Chronic Lung Allograft Dysfunction after Lung Transplantation.
Tikkanen JM; Singer LG; Kim SJ; Li Y; Binnie M; Chaparro C; Chow CW; Martinu T; Azad S; Keshavjee S; Tinckam K
Am J Respir Crit Care Med; 2016 Sep; 194(5):596-606. PubMed ID: 26967790
[TBL] [Abstract][Full Text] [Related]
8. Lung transplantation outcomes after crossing low-level donor specific antibodies without planned augmented immunosuppression.
Courtwright AM; Kamoun M; Diamond JM; Kearns J; Ahya VN; Christie JD; Clausen E; Hadjiliadis D; Patel N; Salgado JC; Cevasco M; Cantu EE; Crespo MM; Bermudez CA
Clin Transplant; 2021 Nov; 35(11):e14447. PubMed ID: 34365656
[TBL] [Abstract][Full Text] [Related]
9. Higher Molecular Injury at Diagnosis of Acute Cellular Rejection Increases the Risk of Lung Allograft Failure: A Clinical Trial.
Keller MB; Tian X; Jang MK; Meda R; Charya A; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
Am J Respir Crit Care Med; 2024 May; 209(10):1238-1245. PubMed ID: 38190701
[No Abstract] [Full Text] [Related]
10. The role of donor-derived exosomes in lung allograft rejection.
Ravichandran R; Bansal S; Rahman M; Sharma M; Liu W; Bharat A; Hachem R; Omar A; Smith MA; Mohanakumar T
Hum Immunol; 2019 Aug; 80(8):588-594. PubMed ID: 30898684
[TBL] [Abstract][Full Text] [Related]
11. Bronchiolitis obliterans syndrome due to donor-specific HLA-antibodies.
Kauke T; Kneidinger N; Martin B; Dick A; Schneider C; Schramm R; Meimarakis G; Preissler G; Eickelberg O; von Dossow V; Behr J; Hatz R; Neurohr C; Winter H
Tissue Antigens; 2015 Sep; 86(3):178-85. PubMed ID: 26204790
[TBL] [Abstract][Full Text] [Related]
12. The Lung Microbiome Predicts Mortality and Response to Azithromycin in Lung Transplant Recipients with Chronic Rejection.
Combs MP; Luth JE; Falkowski NR; Wheeler DS; Walker NM; Erb-Downward JR; Wakeam E; Sjoding MW; Dunlap DG; Admon AJ; Dickson RP; Lama VN
Am J Respir Crit Care Med; 2024 Jun; 209(11):1360-1375. PubMed ID: 38271553
[No Abstract] [Full Text] [Related]
13. Association of positive pre-transplant angiotensin II type 1 receptor antibodies with clinical outcomes in lung transplant recipients.
Son BS; Lee HJ; Cho WH; So MW; Park JM; Yeo HJ
Transpl Immunol; 2023 Oct; 80():101901. PubMed ID: 37442212
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to lung self-antigens (Kα1 tubulin and collagen V) and donor specific antibodies to HLA in lung transplant recipients and implications for lung transplant outcomes: Single center experience.
Rao U; Sharma M; Mohanakumar T; Ahn C; Gao A; Kaza V
Transpl Immunol; 2019 Jun; 54():65-72. PubMed ID: 30794945
[TBL] [Abstract][Full Text] [Related]
15. FCGR3A and FCGR2A Genotypes Differentially Impact Allograft Rejection and Patients' Survival After Lung Transplant.
Paul P; Pedini P; Lyonnet L; Di Cristofaro J; Loundou A; Pelardy M; Basire A; Dignat-George F; Chiaroni J; Thomas P; Reynaud-Gaubert M; Picard C
Front Immunol; 2019; 10():1208. PubMed ID: 31249568
[TBL] [Abstract][Full Text] [Related]
16. Detection and clinical impact of human leukocyte antigen antibodies in lung transplantation: A systematic review and meta-analysis.
Courtwright A; Diamond JM; Wood I; Guleria I; Milford E; El-Chemaly S; Goldberg HJ
HLA; 2018 Feb; 91(2):102-111. PubMed ID: 29178607
[TBL] [Abstract][Full Text] [Related]
17. Changes in HCMV immune cell frequency and phenotype are associated with chronic lung allograft dysfunction.
Rousselière A; Delbos L; Foureau A; Reynaud-Gaubert M; Roux A; Demant X; Le Pavec J; Kessler R; Mornex JF; Messika J; Falque L; Le Borgne A; Boussaud V; Tissot A; Hombourger S; Bressollette-Bodin C; Charreau B
Front Immunol; 2023; 14():1143875. PubMed ID: 37187736
[TBL] [Abstract][Full Text] [Related]
18. The fraction of sensitization among lung transplant recipients in a transplant center in Japan.
Kumata S; Hirama T; Watanabe Y; Oishi H; Niikawa H; Akiba M; Tikkanen J; Okada Y
BMC Pulm Med; 2020 Oct; 20(1):256. PubMed ID: 33008353
[TBL] [Abstract][Full Text] [Related]
19. Safety of Crossing Donor-specific Antibodies in Lung Transplantation.
Wang M; Campbell P; Lien DC; Varughese R; Weinkauf J; Nagendran J; Hirji A; Li D; Halloran K
Transplantation; 2023 May; 107(5):1172-1179. PubMed ID: 36595026
[TBL] [Abstract][Full Text] [Related]
20. Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality.
Lazarte J; Ma J; Martinu T; Levy L; Klement W; White M; Pelling J; Guan Z; Azad S; Tikkanen J; Rao V; Tomlinson G; Delgado D; Keshavjee S; Juvet SC
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31164432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
